Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Li-Zhu Lin"'
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 174, Iss , Pp 116499- (2024)
Externí odkaz:
https://doaj.org/article/c631c7b084914ba59f825d24432f22f5
Autor:
Cai-Zhi Yang, Ting Yang, Xue-Ting Liu, Can-Feng He, Wei Guo, Shan Liu, Xiao-Hui Yao, Xi Xiao, Wei-Ran Zeng, Li-Zhu Lin, Zhong-Yu Huang
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: The function and features of long non-coding RNAs (lncRNAs) are already attracting attention and extensive research on their role as biomarkers of prediction in lung cancer. However, the signatures that are both related to genomic instabi
Externí odkaz:
https://doaj.org/article/e003ce1be69641b1aaa3373aba053779
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 23, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/f655baf4745f4831918a5e8c5987b0d6
Autor:
Wei Liu, Sheng-Xiong Zhang, Bo Ai, Hua-Feng Pan, Dan Zhang, Yu Jiang, Lei-Hao Hu, Ling-Ling Sun, Zhe-Sheng Chen, Li-Zhu Lin
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Ginsenoside Rg3 is a steroidal saponin isolated from Panax ginseng. Previous studies have shown that Rg3 treatment downregulates the activity of rapamycin complex 1 (mTORC1) activity and inhibits the growth of cancer cells. However, the inhibitory ef
Externí odkaz:
https://doaj.org/article/6a87e97bcdcc4a4d8d910474070ea45b
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/512266cbd8ee42829e1b7d4eb4ebfb29
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Altered cellular metabolism is considered to be one of the hallmarks of cancer (Coller, Am J Pathol 184:4–17, 2014; Kim and Bae, Curr Opin Hematol 25:52–59, 2018). However, few studies have investigated the role of metabolism
Externí odkaz:
https://doaj.org/article/433bbe2619a24496994a6295fdd37469
Autor:
Rui-Lian Chen, Ling-Ling Sun, Yang Cao, Han-Rui Chen, Jing-Xu Zhou, Chu-Ying Gu, Ying Zhang, Si-Yu Wang, Wei Hou, Li-Zhu Lin
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundCisplatin-based chemotherapy was previously considered as the standard adjuvant therapy for improved overall survival (OS) in patients with non-small cell lung cancer (NSCLC) after surgery. However, the benefit was limited due to high risks
Externí odkaz:
https://doaj.org/article/9d9f850dc1594d429f349a3aacfa8108
Autor:
Xiao-Zhong Liao, Ying Gao, Hong-Wei Zhao, Mi Zhou, Dan-Lei Chen, Lan-Ting Tao, Wei Guo, Ling-Ling Sun, Chu-Ying Gu, Han-Rui Chen, Zhi-Wei Xiao, Jia-Xing Zhang, Mei-Fang He, Li-Zhu Lin
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2021)
Cisplatin (DDP) is the first-line chemotherapeutic agent against lung cancer. However, the therapeutic effect of DDP loses over time due to the acquired drug resistance in non-small cell lung cancer (NSCLC) cells. In recent years, the role of the tra
Externí odkaz:
https://doaj.org/article/63056f9442a34c3489dadfd1b0eeffbf
Autor:
Cai-Zhi Yang, Lei-Hao Hu, Zhong-Yu Huang, Li Deng, Wei Guo, Shan Liu, Xi Xiao, Hong-Xing Yang, Jie-Tao Lin, Ling-Ling Sun, Li-Zhu Lin
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0260720 (2021)
Globally, non-small cell lung cancer (NSCLC) is the most common malignancy and its prognosis remains poor because of the lack of reliable early diagnostic biomarkers. The competitive endogenous RNA (ceRNA) network plays an important role in the tumor
Externí odkaz:
https://doaj.org/article/a5c2e2c6ecc84c5ea48b55a790b8ee1e
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/46bb71751e7e4223beaef11bf8e16837